
PT-141
Synthetic Research Peptide
Size
10mg
Price
$40.00
In stock
PT-141 is a synthetic melanocortin receptor agonist peptide designed to treat sexual dysfunction and hypoactive sexual desire disorder (HSDD) in both women and men.
- Clearly labeled 10mg vial
- Synthetic peptide
- Guest checkout — order in minutes
For laboratory research use only. Not for human or veterinary use.
Central Nervous System Target: Unlike classic erectile dysfunction medications (PDE5 inhibitors like sildenafil or tadalafil) that act peripherally on blood vessels, PT-141 works centrally in the brain.
Receptor Agonism: It binds to and activates central melanocortin receptors—predominantly \bm{MC_3R} and \bm{MC_4R}—located in the hypothalamus.
Dopamine Pathways: Activation of these receptors stimulates central dopamine release, directly elevating sexual desire, motivation, and physiological arousal.
- Compound
- PT-141
- Also known as
- PT 142, PT142, Bremelanotide, PT-142 peptide
- Quantity
- 10mg
- Compound type
- Synthetic peptide
- Form
- Lyophilized research material
- Research category
- Neuropeptides Research
- Intended use
- Laboratory research only
In laboratory research, PT-142 is utilized to study receptor signaling mechanisms, particularly those involving melanocortin receptors. Researchers investigate its binding affinity, receptor activation, and intracellular signaling cascades in various cell models.
Studies with PT-142 contribute to understanding neuropeptide receptor functions and their role in cellular communication. It is employed in assays designed to elucidate receptor pharmacology and signaling dynamics under controlled experimental conditions.
This information is provided for compound identification and research context only. It is not medical advice and is not a representation that this material is safe or effective for any use in humans or animals.
Orders are processed after payment confirmation and order review.
Shipping methods, carriers and timelines are described in the Shipping Policy. Orders may be reviewed and may be declined at our discretion.



